课题基金 / 基金详情

Molecular regulation of intestinal calcium absorption

Molecular regulation of intestinal calcium absorption
肠道钙吸收的分子调节
批准号:
RGPIN-2015-05842
负责人:
Alexander, RTodd
金额:
$2.04万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Alexander, RTodd的其他基金

相似基金

相关文献

中文摘要
翻译
钙(Ca2+)是无数生理过程的核心。因此,它在等离子体中维持在狭窄的范围内。这是通过肠道吸收、骨沉积/再吸收、过滤和随后的肾脏再吸收之间的动态相互作用来完成的。第一步是肠道Ca2+吸收,它通过两种途径之一发生。Ca2+通过主动的跨细胞(通过上皮细胞)途径或被动的细胞旁途径(上皮细胞之间)吸收。当饮食中有足够的Ca2+时,被动的细胞旁吸收占主导地位。当饮食Ca2+低时,跨细胞运输是重要的。这是由一系列转运和载体事件介导的(图1)。十二指肠被认为是活跃的跨细胞Ca2+吸收的主要部位,尽管新出现的证据,包括我的研究项目,表明近端大肠的作用。肠道Ca2+吸收的主要调节剂是维生素D,它增加了活跃的跨肠Ca2+运输。肾脏通过钙感应受体(CaSR)直接响应细胞外Ca2+。肠道也表达CaSR,然而,其在调节Ca2+吸收中的作用尚不清楚。***我的研究方向是肠道Ca2+吸收的基本分子机制。我使用小鼠模型是因为它们:I)允许在整个生物体的背景下研究Ca2+稳态;Ii)易于采用药理学和遗传学方法,包括过度表达和敲低关键基因;iii)允许在Ussing室中直接测量穿过肠上皮的Ca2+通量,其中电压和浓度梯度受到严格控制,从而能够独立地询问细胞旁和跨细胞途径。***我在未来5年肠道Ca2+吸收研究计划的主要目标有三个方面。1)确定近端大肠在Ca2+吸收中的重要性。我们假设盲肠是Ca2+抢救的场所,最大限度地减少Ca2+损失。为此,我们将测量小鼠近端大肠制剂的Ca2+吸收:i)用促钙激素或Ca2+稳态的药理学调节剂处理;ii)饲喂改变后的含Ca2+饲料;iii)缺乏跨细胞Ca2+通量所需成分的转基因小鼠。2)使用类似的方法,我们将描绘负责在生命早期维持正Ca2+平衡的分子。3)我们将探讨血清Ca2+水平对肠道Ca2+吸收的直接影响以及CaSR在这一过程中的作用。为此,我们将使用CaSR的药理学调节剂,在小鼠肠道中敲低和过表达CaSR。这些研究将解决介导Ca2+稳态的基本机制
英文摘要
Calcium (Ca2+) is central to a myriad of physiological processes. Consequently it is maintained within narrow limits in plasma. This is accomplished by dynamic interplay between intestinal absorption, deposition/resorption from bone and by filtration and subsequent reabsorption by the kidney. The first step is intestinal Ca2+ absorption, which occurs via one of two routes. Ca2+ is absorbed via an active transcellular (through the epithelial cell) pathway, or by a passive paracellular pathway (between epithelial cells). When adequate amounts of Ca2+ are present in the diet, passive paracellular absorption predominates. When, dietary Ca2+ is low, transcellular transport is important. This is mediated by a series of transport and carrier events (Fig 1). The duodenum is thought to be the primary site of active transcellular Ca2+ absorption, although emerging evidence, including from my research program, suggests a role for the proximal large bowel. The primary regulator of intestinal Ca2+ absorption is vitamin D, which increases active transintestinal Ca2+ transport. The kidney responds directly to extracellular Ca2+ via the calcium sensing receptor (CaSR). The intestine also expresses the CaSR, however, its role in regulating Ca2+ absorption is unknown.*** My research program in this area focuses on basic molecular mechanisms regulating intestinal Ca2+ absorption. I use murine models because they: i) permit the study of Ca2+ homeostasis within the context of the whole organism; ii) are readily amenable to pharmacologic and genetic approaches, including over-expression and knockdown of key players; and iii) permit the direct measurement of Ca2+ flux across intestinal epithelium in Ussing chambers where voltage and concentration gradients are tightly controlled,  enabling the interrogation of paracellular and transcellular pathways independently.*** The main objectives of my research program in intestinal Ca2+ absorption over the next 5 years are three-fold. 1) To determine the importance of proximal large bowel in Ca2+ absorption. We hypothesize the cecum is a site of Ca2+ salvaging minimizing Ca2+ loss. To this end, we will measure Ca2+ absorption across proximal large bowel preparations of mice: i) treated with calciotropic hormones or pharmacological regulators of Ca2+ homeostasis; ii) fed altered Ca2+-containing diets; and iii) genetically modified mice lacking components required for transcellular Ca2+ flux. 2) Using similar approaches we will delineate the molecules responsible for maintaining a positive Ca2+ balance early in life. 3) We will explore the direct effect of serum Ca2+ levels on intestinal Ca2+ absorption and the role of the CaSR in this process. To do so we will use pharmacological modulators of the CaSR and both knockdown and over-express the CaSR in the intestine of mice. These studies will address fundamental mechanisms mediating Ca2+ homeostasis.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular regulation of intestinal calcium absorption
  • 批准号:
    RGPIN-2015-05842
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2017
  • 负责人:
    Alexander, RTodd
  • 依托单位:
Molecular regulation of intestinal calcium absorption
  • 批准号:
    RGPIN-2015-05842
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2016
  • 负责人:
    Alexander, RTodd
  • 依托单位:
Molecular regulation of intestinal calcium absorption
  • 批准号:
    RGPIN-2015-05842
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2015
  • 负责人:
    Alexander, RTodd
  • 依托单位:
国内基金
海外基金
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位: